![]() |
|
|
Vol. 291, Issue 1, 335-344, October 1999
Department of Molecular and Cellular Physiology, University of Cincinnati, College of Medicine, Cincinnati, Ohio
| |
Abstract |
|---|
|
|
|---|
We investigated the mechanisms by which hypoxia and alkalinization
inhibit the endothelium-dependent relaxation to Substance P (SP) in
porcine coronary artery. In a KCl contracture, the major component of
the SP response is endothelium-derived nitric oxide (EDNO), whereas
with receptor-mediated
9,11-dideoxy-ll
,9
-epoxymethanoprostaglandin F2
(U46619) stimulation, the SP response is dependent on both EDNO
and endothelium-derived hyperpolarization factor. Intracellular alkalinization by NH4Cl reduced the peak of SP responses
when arteries were contracted with KCl, whereas with U46619
stimulation, the peak was little effected but the duration was
shortened. In endothelial cell-denuded arteries, alkalinization with
NH4Cl shifted the sodium nitroprusside
concentration-relaxation relations rightward. The effects of
NH4Cl in SP- and sodium nitroprusside-induced relaxations were attenuated by decreasing extracellular pH (pHo) from
7.4 to 7.2, which normalized intracellular pH (pHi) to
control levels. In contrast, in U46619 contractures, the SP response in
the presence of a NO synthase inhibitor was unaffected by
NH4Cl. Moreover, hypoxia blunted but did not abolish the
responses to SP for U46619 contractures; addition of KCl, however,
abolished the SP response under hypoxia. Endothelial
[Ca2+]i was measured with fura-2
differentially loaded only into endothelial cells on intact arteries.
Despite the attenuation of the SP response in KCl contractures by
NH4Cl or hypoxia, endothelial
[Ca2+]i responses were unchanged. Our results
suggest that hypoxia and alkalinization inhibit EDNO but not
endothelium-derived hyperpolarization factor relaxations through a
mechanism(s) not involving endothelial cell
[Ca2+]i. Inhibition of EDNO relaxation by
alkalinization with NH4Cl is likely to occur at the level
of activation of guanylate cyclase and/or at a step downstream in
smooth muscle.
| |
Introduction |
|---|
|
|
|---|
Hypoxia
and intracellular pH (pHi) are known to
significantly alter vascular responses (Rubanyi and Paul, 1985
;
Hashimoto et al., 1993
; Nagesetty and Paul, 1994
). Vascular endothelium plays an important role in modulation of vascular tone by releasing a
variety of vasoactive factors, such as endothelium-derived relaxing factor (Furchgott and Zawadzki, 1980
; Vanhoutte and Rimele, 1983
). The
endothelium also probably functions as a sensor of
O2 tension and pH in the arterial wall. Our work
and that of others has shown that hypoxia attenuates
endothelium-dependent relaxation induced by A23187, Substance P (SP),
acetylcholine, and thrombin (deMey and Vanhoutte, 1978
; Johns et al.,
1989
; Hashimoto et al., 1993
). The inhibition of endothelium-dependent
relaxation by hypoxia probably occurs at the level of the vascular
endothelium because relaxation induced by sodium nitroprusside (SNP), a
direct activator of guanylate cyclase, is unimpaired by hypoxia
(Hashimoto et al., 1993
). However, the mechanisms by which hypoxia
inhibit endothelium-dependent relaxation are not clear.
Endothelium-derived relaxation factor has been identified as nitric
oxide (NO) or related compounds (Ignarro et al., 1987
; Palmer et al.,
1987
). NO activates soluble guanylate cyclase and associated
cGMP-mediated relaxation of vascular smooth muscle (Ignarro et al.,
1984
; Murad, 1986
). However, agonist-stimulated endothelium-dependent
relaxation also includes component(s) resistant to inhibitors of NO
synthase and guanylate cyclase (Nishiye et al., 1989
; Rees et al.,
1989
). The NO pathway-resistant relaxation is abolished by high
K+ solutions or the nonselective
K+ channel inhibitor tetrabutylammonium chloride
in porcine coronary artery (Nagao and Vanhoutte, 1992
), and by a
combination of the K+ channel inhibitors
charybdotoxin and apamin in rat hepatic artery (Zygmunt and
Högestätt, 1996
) and guinea pig basilar artery (Petersson
et al., 1997
). This relaxing factor(s) has been termed the
endothelium-dependent hyperpolarizing factor (EDHF) in porcine coronary
artery and other tissues (for review, see Cohen and Vanhoutte, 1995
).
Thus, there may be at least two components in SP-induced relaxation,
including NO and EDHF in porcine coronary artery.
Using novel methodology involving selective loading of fluorescent
dyes, Foy et al. (1997)
showed that hypoxia increased
pHi in endothelium in situ on intact arteries.
Whether the inhibition of endothelium-dependent relaxation by hypoxia
can be attributed to this alkalinization is not known. Moreover, the
effects of hypoxia and/or alkalinization on endothelium-derived nitric
oxide (EDNO) or EDHF per se are not known. In this study, we thus
tested the hypothesis that hypoxia and the concomitant alkalinization differentially affect the responses attributable to EDNO and EDHF. We
used novel methodology to measure endothelial cell
[Ca2+]i in situ on the
intact coronary artery to probe the mechanism of the differential
inhibitory effects observed.
| |
Materials and Methods |
|---|
|
|
|---|
Preparation of Arterial Rings.
Porcine hearts were obtained
from a local slaughterhouse and transported to the laboratory immersed
in ice-cold lactated Ringer's solution. The distal portions of left
anterior descending coronary artery were dissected from the hearts and
were cleaned of fat and adhering connective tissue, with care taken to
prevent stretching of the vessel. Blood clots in the lumen were flushed
out with ice-cold oxygenated (95% O2/5% CO2)
Krebs-bicarbonate buffer. The arteries were then cut into rings 4 to 5 mm in length. In some experiments, the arterial rings were everted and
the endothelium was removed by gently rubbing with cotton. Arteries
were stored in Krebs-bicarbonate buffer at 4°C for up to 2 days;
these stored arteries are similar to that of fresh tissue (Hashimoto et
al., 1992
; Shimizu et al., 1997
).
Isometric Force Measurements.
Arterial rings were mounted on
two stainless steel wires, one stationary and the other attached to a
force transducer (Kistler-Morse DSK-6, Bellevue, WA). Output from the
force transducer was recorded on dual channel recorder (Linear 1200;
Linear Instruments, Irvine, CA) and a computer data collection (BioPac)
and analysis (AcqKnowledge III) system (Goletta, CA). The rings
were incubated in Krebs-bicarbonate buffer in 15-ml water-jacketed
chambers. The solution was maintained at 37°C and bubbled with 95%
O2/5% CO2 for aerobic conditions. Hypoxic
conditions were defined by bubbling with 95% N2/5%
CO2 (PO2 ~1-2%). The rings were
equilibrated for 90 min and were periodically stretched to obtain a
resting tension of 40 mN, optimal for isometric force (Rubanyi and
Paul, 1985
). After the equilibration period, the arteries were
contracted with 80 mM KCl until successive challenges gave stable
contractions of equivalent magnitudes. Endothelial integrity and the
effectiveness of the denudation technique were assessed by the addition
of SP (10 nM) to arteries precontracted with KCl.
,9
-epoxymethanoprostaglandin F2
(U46619, 0.1 µM) or KCl (30 or 50 mM), and the relaxation
induced by SP (10 nM) was recorded. KCl-induced contractions were
elicited by addition of an aliquot of 3 mol/l KCl to give the desired
final concentration. All inhibitors, including NG-nitro-L-arginine
(L-NNA), tetrabutylammonium chloride (TBA), quinacrine, indomethacin, and SKF-525a were added to the tissue baths
at least 15 min before contraction with U46619 or KCl. Relaxations were
expressed as a percentage of the tone induced by 80 mM KCl. To
quantitate the duration of SP-induced relaxation, the recovery half-time (T1/2, time from peak to 50%
recovery) of SP responses was measured.
Measurement of [Ca2+]i in Endothelium
on Intact Porcine Coronary.
Endothelial
[Ca2+]i was measured with the
Ca2+-sensitive fluorescent dye fura-2 by using a
modification technique for endothelial pHi measurement (Foy
et al., 1997
). The coronary ring was cut open and sutured endothelial
side out onto a U-shaped hook that was connected to a Teflon holder.
After equilibration, the tissue was incubated in a
3-(N-morpholino)propanesulfonic acid (MOPS)-buffered physiological saline solution (pH 7.4) containing 10 µM fura-2 acetoxymethylester, 0.02% cremophor, and 2 mg/ml BSA for 20 to 30 min at room temperature in a cuvette (2.4 ml) with stirring. The
preparation was then mounted in the sample compartment of a
spectrofluorimeter (Photon Technologies, Inc., Santa Clara, CA)
configured for front face measurement and continuously perfused with
Krebs-bicarbonate buffer (pH 7.4), maintained at 37°C and gassed with
95% O2 and 5% CO2. After 15 to 30 min,
fluorescence intensity was measured at excitation wavelengths of 340 and 380 nm and an emission wavelength of 510 nm.
[Ca2+]i Calibration. The fluorescence intensity at 340 nm excitation was divided by that measured at 380 nm, and this ratio was used as an index of [Ca2+]i. For statistical analysis, the ratio of the SP response was divided by the maximum ratio obtained with the Ca2+ ionophore ionomycin (5 µM) and data are shown as a percentage of ionomycin response.
Measurement of pHi in Coronary Artery Smooth
Muscle.
pHi in coronary artery smooth muscle was
measured as described in Nagesetty and Paul (1994)
. The coronary ring
was everted and the endothelium was removed by gently rubbing with
cotton. The preparation was isometrically mounted on a U-shaped wire
and incubated in Krebs-bicarbonate buffer for at least 1 h. At end of the equilibration period the U-shaped wire with tissue was connected
to a Teflon holder and placed in a cuvette (2.4 ml). The tissue was
oriented perpendicular to the beam of light for front face measurements
in a spectrofluorimeter (Photon Technologies, Inc.) and perfused with
Krebs-bicarbonate buffer. After the autofluorescence of the preparation
was measured, tissue perfusion was discontinued and
2',7'-biscarboxyethyl-5(6)-carboxyfluorescein tetraacetoxymethylester (BCECF-AM, 5 µM) was added to the cuvette. Fluorescence was measured at an emission wavelength of 523 nm with excitation wavelengths of 439 and 505 nm. Loading was stopped when the 505-nm signal was at least 10 times the baseline at which time the 439-nm signal was at least 3 times
baseline. Perfusion of the tissue was reinitiated to wash out the
unhydrolyzed BCECF-AM. After a stable baseline was achieved,
pHi was measured.
pHi Calibration.
Absolute values of
pHi were determined with an adaptation of the high
K+-nigericin technique reported in Thomas et al. (1979)
. At
the end of the experiment, nigericin (5 µM) was added to the cuvette and a calibration curve was constructed with high
K+-MOPS-buffered solutions of known pH values (6.80-7.81).
The ratio of the fluorescence intensities at 505 nm and 439 nm minus
the tissue autofluorescence was nearly linearly related to
pHi. Photon Technologies, Inc. software "look up
tables" (i.e., segmental lines fitted to the calibration data) were
used to convert fluorescent intensity ratios to pHi values
for each individual preparation.
Solutions and Chemicals.
The Krebs-bicarbonate solution (pH
7.4) used in these experiments had the following composition: 118 mmol/l NaCl, 4.7 mmol/l KCl, 2.5 mmol/l CaCl2, 1.18 mmol/l
KH2PO4, 1.18 mmol/l MgSO4, 15 mmol/l NaHCO3, 0.026 mmol/l EDTA, and 11 mmol/l glucose.
Decreasing pH from 7.4 to 7.2 was carried out by decreasing
HCO3 in the Krebs' bicarbonate buffer. The MOPS-buffered
physiological saline solution used had the following composition: 140 mmol/l NaCl; 4.7 mmol/l KCl; 1.2 mmol/l
NaH2PO4; 20 mmol/l MOPS; 0.02 mmol/l EDTA; 1.2 mmol/l MgSO4; 2.5 mmol/l CaCl2; and 11 mmol/l
glucose, pH 7.4. The drugs used in this study were U46619 (in ethanol),
SP (in water), L-NNA (dissolved in Krebs-bicarbonate
solution), tetrabutylammonium chloride (dissolved in Krebs-bicarbonate
solution), indomethacin (in ethanol), quinacrine (in distilled water),
SKF-525a (dissolved in Krebs-bicarbonate solution), fura-2 AM (in
dimethyl sulfoxide), BCECF-AM (in dimethyl sulfoxide), and nigericin
(in ethanol). The final concentration of vehicle, acetone, and ethanol
did not exceed 0.1%, below which no vehicle effects were found
(Hashimoto et al., 1993
).
Statistical Analysis. Data are presented as mean ± S.E. Differences between groups were assessed by one-way ANOVA or two-tailed Student's t test for paired data as appropriate. Differences among means were considered significant when P < .05.
| |
Results |
|---|
|
|
|---|
Components of SP-Induced Endothelium-Dependent Relaxation and
Effects of Alkalinization by NH4Cl.
We first used a
pharmacological approach to identify the components of SP-induced
relaxation in KCl and U46619 contractures. Figure
1 presents the force records for a
typical experiment and the average values are summarized in Table
1. For contractures elicited by 30 mM
KCl, SP (10 nM) relaxed intact but not de-endothelialized coronary
arteries. The endothelium-dependent SP-induced relaxations were
inhibited by 0.2 mM L-NNA, a potent inhibitor of NO
synthase (Fig. 1A). In contrast, in U46619 contractures (Fig. 1B), the magnitude of the decrease in force in response to SP (the peak of
relaxation) was not inhibited by 0.2 mM L-NNA. However, the SP response was nearly abolished by further addition of 5 mM TBA, a
nonselective inhibitor of K+ channels.
|
|
|
|
|
Does Alkalinization by NH4Cl Affect SP-Induced Increase
in Endothelial [Ca2+]i?
NO synthesis in
vascular endothelium has been reported to depend on
[Ca2+]i (Mayer et al., 1989
; Schmidt et al.,
1992
). We tested this hypothesis in the intact artery by measuring the
effects of SP on endothelial [Ca2+]i, with
our protocol (Foy et al., 1997
) for loading fura-2 only into the
endothelium of an intact porcine coronary artery (Fig. 4A). Addition of 30 mM KCl did not affect
the basal fluorescence ratio (340:380), whereas 10 nM SP significantly
increased the fluorescence ratio of the endothelium-loaded preparation
(Fig. 4A). However, after rubbing the artery to remove the endothelium, addition of SP did not elicit a response. In sharp contrast, when the
de-endothelialized artery was loaded with fura-2, the smooth muscle
responded to 30 mM KCl with a sustained increase in the 340:380 ratio,
whereas SP was without effect (Fig. 4B). Vascular endothelial cells are
generally suggested to lack voltage-activated Ca2+ channels
(Adams et al., 1989
). These data attest to the specificity of our dye
loading for the endothelial cell layer of the intact artery.
|
|
Effect of Alkalinization by NH4Cl on SNP-Induced
Relaxation.
To determine whether alkalinization by
NH4Cl inhibits EDNO-mediated relaxation upstream or
downstream of activation of guanylate cyclase, we investigated the
effect of 30 mM NH4Cl on the SNP-induced relaxation in
de-endothelialized coronary arteries in 30 mM KCl contractures (Fig.
6). SNP releases NO, which activates
guanylate cyclase. SNP elicited a concentration-dependent relaxation
that was shifted rightward by 30 mM NH4Cl. The effects of
NH4Cl were attenuated by decreasing pHo from
7.4 to 7.2, as was the case for the SP-induced relaxation.
|
Effects of Hypoxia on Endothelium-Dependent Relaxation.
We
have shown that hypoxia inhibits SP-induced relaxation when arteries
were contracted with KCl (Hashimoto et al., 1993
). To determine the
effects of hypoxia on EDHF-dependent relaxation, we investigated the
effect of hypoxia on SP-induced relaxation in U46619 contractures (Fig.
7 and Table
3). As we have previously shown, hypoxia
relaxed steady-state contractions independent of the kind of
stimulation. The degree of the hypoxia-induced relaxation in U46619
contractures was larger than that in KCl contractures. In 50-mM KCl
contractures, hypoxia inhibited the SP-induced relaxation (Hashimoto et
al., 1993
). However, the SP-induced relaxation was observed under
hypoxic conditions for U46619 contractures and this relaxation was not
inhibited by 0.2 mM L-NNA but was inhibited by 5 mM TBA.
|
|
Effects of Hypoxia on SP-Induced Increase in Endothelial
[Ca2+]i.
Figure
8 shows the effect of hypoxia on the
SP-induced increase in endothelial [Ca2+]i in
the presence of 30 mM KCl. Addition of 30 mM KCl did not affect a basal
fluorescence ratio (340:380). SP (10 nM) significantly increased the
fluorescence ratio. Importantly, however, the SP-induced [Ca2+]i response was not affected by hypoxia;
39.9% ± 1.2% versus 42.6% ± 2.6% of the ionomycin response for
control and hypoxia, respectively (n = 4).
|
Is EDHF a P-450-Derived Arachidonic Acid Metabolite?
EDHF has
not been identified. However, it has been reported that EDHF is
synthesized by a P-450-dependent mechanism via arachidonic acid
metabolism in various arteries, including bovine coronary artery
(Hecker et al., 1994
; Campbell et al., 1996
) and porcine coronary
artery (Hecker et al., 1994
). NO synthase also has P-450-like domain.
Interestingly, despite the inhibition by alkalinization or hypoxia of
the EDNO response, the EDHF response was not similarly affected.
Therefore, we investigated whether EDHF also is synthesized via a P-450
pathway in porcine coronary artery (Table
4). Pretreatment with 10 µM
indomethacin (a cyclooxygenase inhibitor), 30 µM quinacrine (a
phospholipase A2 inhibitor), or 30 µM SKF-525a (a P-450
inhibitor) did not affect the 0.1 µM U46619-induced contraction.
Importantly, the component of the SP relaxation seen in the presence of
0.2 mM L-NNA also was not affected by these interventions.
|
| |
Discussion |
|---|
|
|
|---|
Hypoxia inhibits the endothelium-dependent relaxation elicited by
SP in KCl contractures in porcine coronary artery (Hashimoto et al.,
1993
). Foy et al. (1997)
previously showed that hypoxia increases
pHi in endothelium in situ on intact arteries.
This inhibition probably occurs at the level of the vascular
endothelium because the relaxation of the smooth muscle by the NO donor
SNP, which directly activates guanylate cyclase, was not affected by hypoxia (Hashimoto et al., 1993
). In this study, we tested the hypothesis that hypoxia and the concomitant alkalinization inhibit endothelium-dependent relaxation in porcine coronary artery.
We first determined the components of SP responses in KCl and U46619
contractures. In KCl contractures, the SP-induced relaxation was
abolished by inhibition of NO synthase. Thus, the major component of
the SP-induced relaxation in KCl contractures is probably mediated by
NO. However, when arteries were contracted with U46619, the major
effect of NO synthase inhibition was to shorten the duration of the SP
response (Table 1). Further addition of a nonselective K+ channel inhibitor blocked the remaining
relaxation. It has been suggested that a hyperpolarizing factor is
released from endothelium in various arteries (Brayden, 1990
; Chen et
al., 1991
; Nagao and Vanhoutte, 1992
; Shimizu and Paul, 1997
). Nagao
and Vanhoutte (1992)
showed that the use of L-NNA, TBA, or
high K+ permits differentiation between
endothelium-dependent relaxations mediated by NO and hyperpolarization
in porcine coronary artery. Thus, in KCl contractures, EDHF would be
attenuated and the remaining component of the SP response may be
ascribable to NO. However, in U46619 contractures, the SP response is
attributable to both NO and EDHF. The contribution of prostacycline is
unlikely because indomethacin, an inhibitor of cyclooxygenase, did not
affect either the duration or the peak of the SP response.
Hypoxia and NH4Cl nearly abolished the SP-induced
relaxation when arteries were contracted with KCl. We used
NH4Cl to increase pHi
without altering pHo (Thomas, 1974
). This
standard technique is based on the rapid diffusion of
NH3 into the cell and its re-equilibration with
NH4+. Ando and Fujita (1994)
also showed that addition of NH4Cl inhibited acetylcholine-induced relaxation in rat aorta and the inhibitory effect
was blocked by the H+ ionophore nigericin, which
increases intracellular H+ concentration. In this
study, decreasing pHo, such that the increase in
pHi in response to NH4Cl
returned pHi to the original control levels,
attenuated the effects of NH4Cl on SP-mediated
relaxation. This finding implies that intracellular alkalinization is
probably the most important factor in the inhibition by
NH4Cl of the SP-induced, NO-dependent relaxation.
Thus, hypoxia or intracellular alkalinization by
NH4Cl inhibit SP-induced NO-dependent relaxation.
In contrast, the EDHF response was not affected by either hypoxia or
intracellular alkalinization by NH4Cl. We showed
that EDHF-mediated relaxation in porcine coronary artery is inhibited by 4-aminopyridine, suggesting that it probably involves
Kv channels (Shimizu and Paul, 1997
). Based on
our data in this study, these Kv channels are not
sensitive to O2 or alkaline pH, thus limiting the
potential members of this K+-channel family that
may be involved.
The release of NO requires an increase in
[Ca2+]i in endothelial
cells (Mayer et al., 1989
; Förstermann et al., 1991
;
Schmidt et al., 1992
). Acute hypoxia has been shown to reduce
Ca2+ influx and to decrease
[Ca2+]i in bovine
pulmonary artery endothelial cells (Stevens et al., 1994
) but
has been suggested to increase
[Ca2+]i in human
endothelial cells (Arnould et al., 1992
). These reports on
endothelial [Ca2+]i used
cultured endothelial cells. However, there may be differences between
the responses of cultured cells and those of the endothelium in contact
with its normal smooth muscle substratum in an intact artery. We
measured endothelial
[Ca2+]i in situ with
fura-2 in intact porcine coronary artery. In arteries in which fura-2
was loaded with our endothelium loading protocol, infusion of high
K+ solution did not alter the basal fluorescence
ratio, in contrast to that observed for fura-loaded smooth muscle of
the endothelium-denuded preparation. This result would be anticipated
because endothelial cells are generally considered to lack
voltage-activated Ca2+ channels (Adams et al.,
1989
). However, SP increased endothelial [Ca2+]i, whereas the
smooth muscle was unaffected. These results confirm known smooth muscle
and endothelial cell behavior and attest to the selectivity of our
loading protocol for the endothelium. Thus, we have developed a novel
method of measurement of
[Ca2+]i, in addition to
pHi (Foy et al., 1997
), in endothelium in situ on
intact coronary artery.
Despite the inhibition by NH4Cl and hypoxia of
the SP response in KCl contractures, endothelial
[Ca2+]i responses were
unchanged. Thus, a mechanism involving attenuation of the endothelial
[Ca2+]i response to SP
does not underlie the inhibition by NH4Cl
alkalinization or hypoxia of the SP-induced NO-dependent relaxation.
The production of EDHF also is reported to be dependent on an increase
in [Ca2+]i in endothelial
cells (Chen and Suzuki, 1990
). Thus, the lack of inhibition by hypoxia
or intracellular alkalinization of the SP-induced EDHF response is
consistent with their lack of effect on endothelial
[Ca2+]i .
Foy et al. (1997)
found that in the presence of KCl, hypoxia increased
pHi from 6.8 to 7.0 in the endothelium of intact
arteries. Fleming et al. (1994)
, however, reported that endothelial NO
synthase is activated by intracellular alkalinization at basal levels
of [Ca2+]i with the pH
optimum of 7.5. Therefore, intracellular alkalinization by hypoxia or
NH4Cl may not inhibit NO synthase activity
directly. In endothelium-denuded arteries, alkalinization with
NH4Cl shifted the SNP concentration-relaxation
relation rightward. In contrast, hypoxia does not affect the
SNP-induced relaxation (Hashimoto et al., 1993
) or
S-nitroso-N-acetyl-DL-penicillamine-induced
relaxation (data not shown) in endothelial cell-denuded arteries. This
finding is consistent with the lack of effect of hypoxia on
pHi in coronary artery smooth muscle (Foy et al.,
1997
). These findings suggest that inhibition of the SP relaxation by
hypoxia and by NH4Cl alkalinization involves
different mechanisms. Intracellular alkalinization in endothelial cells
by hypoxia is not likely to be involved in the attenuation of the
SP-induced EDNO-dependent relaxation. Moreover, our results suggest
that it is not downstream from guanylate cyclase. Production of NO
requires molecular oxygen as one of the substrates for the enzyme.
Rengasamy and Johns (1991)
demonstrated that hypoxia inhibits NO
synthase activity primarily through depletion of oxygen. Therefore,
depletion of oxygen may be the most important mechanism of the
inhibition by hypoxia of SP-induced EDNO-dependent relaxation.
In contrast to hypoxia, alkalinization with NH4Cl shifted the SNP concentration-relaxation relation rightward in endothelium-denuded arteries. This shift was partially reversed by decreasing pHo. This finding suggests that at least part of the inhibition of the EDNO component of the SP relaxation by alkalinization may involve guanylate cyclase activation or other mechanisms of smooth muscle relaxation downstream from this point.
In this study, we showed that hypoxia inhibits SP-induced EDNO but not
EDHF relaxation. NO is synthesized by NO synthase, which has a
cytochrome P-450 monooxygenase-like domain (Bredt et al., 1991
).
Interestingly, EDHF also has been suggested to be a cytochrome
P-450-derived arachidonic acid metabolite in various arteries,
including bovine coronary artery (Hecker et al., 1994
; Campbell et al.,
1996
) and porcine coronary artery (Hecker et al., 1994
). However, there
are many reports that argue that EDHF is not a cytochrome P-450
metabolite of arachidonic acid (Corriu et al. 1996
; Fukao et al., 1997
;
Yamanaka et al., 1998
). Edwards et al. (1998)
reported that
K+ is an EDHF in rat arteries. Thus, whether EDHF
is a product of the P-450 pathway is controversial. Cytochrome P-450
requires molecular oxygen as a substrate, and the oxygen sensitivity of the enzyme is similar to that of NO synthase (McGiff, 1991
; Moncada and
Higgs, 1993
). However, EDNO- but not EDHF-mediated relaxation was
inhibited by hypoxia. Petersson et al. (1998)
also reported that
EDHF-mediated relaxation to acetylcholine or the calcium ionophore
A23187 were not inhibited by hypoxia in guinea pig basilar artery.
These findings suggested that EDHF may not be synthesized by the P-450
pathway in these arteries.
In conclusion, we have shown that hypoxia and intracellular alkalinization by NH4Cl inhibit EDNO- but not EDHF-mediated relaxation. The mechanism of inhibition of the EDNO component of relaxation by hypoxia and by alkalinization are probably attributable to different mechanisms. Our results suggest that EDHF may not be produced by a P-450 pathway in porcine coronary artery because the SP-induced EDHF relaxation was not inhibited by hypoxia or cytochrome P-450 inhibitors. It is interesting to speculate that EDHF mechanisms may have evolved to compensate for the failure of EDNO relaxation mechanisms under hypoxia or alkaline conditions.
| |
Footnotes |
|---|
Accepted for publication June 5, 1999.
Received for publication January 21, 1999.
1 Supported by National Institutes of Health HL23240 and American Heart Association SW-95-40-S (to R.J.P.).
Send reprint requests to: Richard J. Paul, Ph.D., Department of Molecular and Cellular Physiology, University of Cincinnati College of Medicine, 231 Bethesda Ave., Cincinnati, OH 45267-0576. E-mail: richard.paul{at}uc.edu
| |
Abbreviations |
|---|
pHi, intracellular pH; SP, substance P; SNP, sodium nitroprusside; NO, nitric oxide; EDHF, endothelium-derived hyperpolarizing factor; EDNO, endothelium-derived nitric oxide; [Ca2+]i, intracellular calcium concentration; L-NNA, NG-nitro-L-arginine; TBA, tetrabutylammonium chloride; MOPS, 3-(N-morpholino)propanesulfonic acid; BCECF-AM, 2',7'-biscarboxyethyl-5(6)-carboxyfluorescein tetraacetoxymethylester; pHo, extracellular pH.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Schafer, D. Bahde, B. Bosche, Y. Ladilov, C. Schafer, H. M. Piper, and T. Noll Modulation of early [Ca2+]i rise in metabolically inhibited endothelial cells by xestospongin C Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1002 - H1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Fortner, J. N. Lorenz, and R. J. Paul Chloride channel function is linked to epithelium-dependent airway relaxation Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L334 - L341. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Clark and L. C. Fuchs BKCa channels compensate for loss of NOS-dependent coronary artery relaxation in cardiomyopathy Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2598 - H2603. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||